Intellasia East Asia News - Aptorum Group Announces Completion of Phase I Clinical Trials for ALS-4 and SACT-1, Small Molecule Drugs Targeted for Infections Caused by Staphylococcus Aureus and Neuroblastoma
Neuroblastoma Treatment and Clinical Trials
Results of a prospective clinical trial JN‐L‐10 using image‐defined risk factors to inform surgical decisions for children with low‐risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee -
Drugs of clinical trials for HR neuroblastoma interventetion | Download Table
Clinical trial for children with high-risk neuroblastoma open — Neuroblastoma UK
First-in-humans clinical trial to treat children with relapsed neuroblastoma opens at American Family Children's Hospital
Cooperative Clinical Trials with 13-Cis-Retinoic Acid in Neuroblastoma Katherine K. Matthay, M.D University of California, San Francisco Children's Oncology. - ppt download
SIOPEN High-Risk Neuroblastoma Clinical Trial 2 to open in the UK in 2021 — Neuroblastoma UK
Targets and Antibody Formats for Immunotherapy of Neuroblastoma | Journal of Clinical Oncology
Current open clinical trials for refractory and relapsed neuroblastoma. | Download Table
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma | Journal of Experimental & Clinical Cancer Research | Full Text
Drugs of clinical trials for HR neuroblastoma interventetion | Download Table
Neuroblastoma Clinical Trials - CNCF
CCF on Twitter: "Around 40 children are diagnosed with Neuroblastoma each year. Our funding of the SIOPEN Neuroblastoma Clinical Trials at #ANZCHOG will help identify better therapies and give hope to these
Frontiers | CAR T Cell Therapy for Neuroblastoma | Immunology
Dinutuximab beta for the Treatment of Neuroblastoma - Clinical Trials Arena
New Treatment Boosts Survival in Kids with Neuroblastoma - NFCR
TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. - SOON TO OPEN IN THE U.S. AND GERMANY - Band of Parents
Too many targets, not enough patients: rethinking neuroblastoma clinical trials | Nature Reviews Cancer
Doxorubicin for Newly Diagnosed High Risk Neuroblastoma Clinical Trial | Power